hereditary

Low-Density Cholesterol Subfractions: Not all LDL-C Particles are Created Equal

...ures LDL particle size and density, in addition to hereditary risk factor and remnant lipoprotein, giving a more accurate depiction of the patients risk for CAD, CHD and metabolic syndrome. Other analyses physically separate and break down lipoproteins. The SPIFE Lipoprotein analyzer (Helena Laboratories) off...

Haemacure Announces Preliminary Findings of its Plasma Discard Analysis

...the market. A1PIis used by patients suffering from hereditary emphysema resultingfrom A1PI deficiency. A1PI deficiency affects between 60,000 to100,000 people in the United States. According to Cowen and Company, enzyme replacement therapies(ERTs) will reach US$3.1B in 2011. ERTs are the cornerstone oftreatmen...

Cogane Data Presented at ‘11th International Congress of Parkinson’s Disease and Disorders’

...sease),though some cases have been found to have a hereditary component(familial Parkinson's disease) and possible mechanisms includeoxidative damage of nerve cells coupled with loss of neurotrophicfactors. Neurotrophic factors are essential for the survival andmaintenance of nerve cells and provide protection ...

Lev Pharmaceuticals Completes Phase III Prophylaxis Trial of C1-Esterase Inhibitor for Hereditary Angioedema

... to sustained relief of acute HAE symptoms.HAE, or hereditary C1-inhibitor deficiency, is a rare andlife-threate... obtaining more informationabout Lev's studies for hereditary angioedema should contact theCompany directly at 212-682-3096, or visit the Company's website at<...

DX-88 for Hereditary Angioedema Meets Primary and Secondary Endpoints in Phase 3 Trial (EDEMA3)

...its lead productcandidate DX-88 (ecallantide), for hereditary angioedema (HAE). Awebcast presentation of the EDE...s and a Phase 3 trial of DX-88 for thetreatment of hereditary angioedema (HAE). A confirmatory study,known as EDEMA4, is planned and expected to begin in the firs...

Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III Trial for Hereditary Angioedema

...erase inhibitor (C1-INH)for the acute treatment of hereditary angioedema (HAE). In theacute study, which is part...ive Officer. About Hereditary Angioedema HAE, or hereditary C1-inhibitor deficiency, is a geneticdisorder characterized by recurrent attacks of inflammationaffe...